Cost-Benefit Analysis of Providing Non-Emergency Medical Transportation
April, 2019
For prenatal care, asthma, congestive heart failure, and diabetes, improved transportation produces net cost savings.
April, 2019
For prenatal care, asthma, congestive heart failure, and diabetes, improved transportation produces net cost savings.
January, 2014
Of the Medicaid beneficiaries with congestive heart failure in rural areas, 70.77% of those who employed NEMT services completed the 10 visits per year whereas only 27.03% of those who did not use NEMT services made the 10 visits
January, 2014
8.19% of Medicaid beneficiaries with congesitve heart failure living in urban areas used NEMT services. Of these, 55.81% made the prescribed number of 10 visits or more while only 28.22% of those who did not use the NEMT services made the recommended number of visits.
January, 2006
Adding relatively small transportation costs to an otherwise disease-specific, cost-effective environment does not make improved access to care non-cost-effective. For example, a congestive heart failure monitoring program that is already evaluated as highly cost-effective will not transition to cost-ineffective because of the addition of only incremental transportation costs.
January, 2006
Authors find that the provision of NEMT to those who currently lack it results in a net cost savings across the transportation and health care domains for four of these conditions (prenatal care, asthma, heart disease, and diabetes) and is cost-effective for the remaining eight conditions (influenza vaccinations, breast cancer screening, colorectal cancer screening, dental […]